The risk for sudden cardiac death (SCD) in adolescents and young adults with hypertrophic cardiomyopathy (HCM) is "an order of magnitude lower" than most recent estimates would indicate, a report ...
Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure.
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...
The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic ...
The AI model MAARS showed good results flagging arrhythmic risk in hypertrophic cardiomyopathy. MAARS takes inputs from electronic medical records, cardiac MRI scans with late gadolinium enhancement, ...
A contrast-enhanced cardiac MRI of a patient with hypertrophic cardiomyopathy deemed by MAARS to be at high risk for sudden death. Each image slice through the heart goes from dark (normal heart ...
A groundbreaking AI tool could soon help prevent sudden cardiac deaths by accurately identifying high-risk patients with a dangerous heart condition—before it’s too late. The new model, developed by ...
Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and expand ...
A recent study found that Sodium-glucose co-transporter 2 (SGLT2) inhibitors use in hypertrophic cardiomyopathy (HCM) ...
New research can transform how hospitals triage, risk-stratify, and counsel patients to save lives. Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) ...
27don MSN
Are South Indians at higher risk of heart disease? New inStem study reveals unique genetic signature
The study, which performed detailed genetic analysis on a cohort of 335 primary HCM patients from South India, found that the genetic landscape of this population is markedly different from that seen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results